You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

Prevail Therapeutics, Inc. (Add-on Acquistion, in 2020)

Transaction #132391
Investor
1
Sign up to view
Target Company
Prevail Therapeutics, Inc.
Life Science · United States
Sellers
No seller data
880 USD
Deal Value
15 Dec 2020
Announced
Target Company
Company Sector Entity Type Status State Country
Prevail Therapeutics, Inc. Life Science Private Active New York (NY) United States
Investors 1
InvestorInvestment TypeAmount% Holding
View 1 Investor
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers
Seller
View Sellers
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the Prevail Therapeutics, Inc. acquisition deal?
This transaction is an acquisition of Prevail Therapeutics, Inc. (Add-on Acquistion) in 2020. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the Prevail Therapeutics, Inc. acquisition happen?
This transaction was announced on 15 Dec 2020.
What is the deal value of the Prevail Therapeutics, Inc. acquisition?
The deal value for this transaction is 880 USD.
Who are the investors in the Prevail Therapeutics, Inc. transaction?
This transaction has 1 investor. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full Prevail Therapeutics, Inc. deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial